Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development
Open Access
- 1 January 2020
- journal article
- review article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 36 (1) , 25-29
Abstract
In this study, we describe efforts by the National Eye Institute (NEI) and National Center for Advancing Translational Science (NCATS) to catalyze advances in 3-dimensional (3-D) ocular organoid and microphysiological systems (MPS). We reviewed the recent literature regarding ocular organoids and tissue chips. Animal models, 2-dimensional cell culture models, and postmortem human tissue samples provide the vision research community with insights critical to understanding pathophysiology and therapeutic development. The advent of induced pluripotent stem cell technologies provide researchers with enticing new approaches and tools that augment study in more traditional models to provide the scientific community with insights that have previously been impossible to obtain. Efforts by the National Institutes of Health (NIH) have already accelerated the pace of scientific discovery, and recent advances in ocular organoid and MPS modeling approaches have opened new avenues of investigation. In addition to more closely recapitulating the morphologies and physiological responses of in vivo human tissue, key breakthroughs have been made in the past year to resolve long-standing scientific questions regarding tissue development, molecular signaling, and pathophysiological mechanisms that promise to provide advances critical to therapeutic development and patient care. 3-D tissue culture modeling and MPS offer platforms for future high-throughput testing of therapeutic candidates and studies of gene interactions to improve models of complex genetic diseases with no well-defined etiology, such as age-related macular degeneration and Fuchs' dystrophy.Keywords
This publication has 38 references indexed in Scilit:
- Generation of retinal ganglion cells with functional axons from human induced pluripotent stem cellsScientific Reports, 2015
- Loss of MITF expression during human embryonic stem cell differentiation disrupts retinal pigment epithelium development and optic vesicle cell proliferationHuman Molecular Genetics, 2014
- Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCsNature Communications, 2014
- Microphthalmia-associated Transcription Factor (MITF) Promotes Differentiation of Human Retinal Pigment Epithelium (RPE) by Regulating microRNAs-204/211 ExpressionJournal of Biological Chemistry, 2012
- Self-Formation of Optic Cups and Storable Stratified Neural Retina from Human ESCsCell Stem Cell, 2012
- Self-organizing optic-cup morphogenesis in three-dimensional cultureNature, 2011
- Three Gene-Targeted Mouse Models of RNA Splicing Factor RP Show Late-Onset RPE and Retinal DegenerationInvestigative Ophthalmology & Visual Science, 2011
- RNA Binding Protein with Multiple Splicing: A New Marker for Retinal Ganglion CellsInvestigative Ophthalmology & Visual Science, 2010
- Study of Gene-Targeted Mouse Models of Splicing Factor GenePrpf31Implicated in Human Autosomal Dominant Retinitis Pigmentosa (RP)Investigative Ophthalmology & Visual Science, 2009
- RNAi knockdown of hPrp31 leads to an accumulation of U4/U6 di‐snRNPs in Cajal bodiesThe EMBO Journal, 2004